Gritstone Reports Second Quarter 2021 Financial Results and Business Update
GRANITE Phase 1/2 data of individualized neoantigen immunotherapy in advanced solid tumors accepted for mini- oral presentation at ESMO 2021 Gritstone-sponsored CORAL (second-generation SARS-CoV-2 vaccine) studies to launch before year-end…